medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2019, Number 1

<< Back

Rev Invest Clin 2019; 71 (1)

Small Airway Disease in COPD Associated to Biomass Exposure

Ramírez-Venegas A, Torres-Duque CA, Guzmán-Bouilloud NE, González-García M, Sansores RH

Language: English
References: 65
Page: 70-78
PDF size: 271.31 Kb.


ABSTRACT

Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous entity that may result from different causative agents and risk factors and may follow diverse clinical courses, including COPD secondary to biomass smoke exposure. At present, this phenotype is becoming more important for two reasons: first, because at least almost half of the world’s population is exposed to biomass smoke, and second, because the possibility of it being diagnosed is increasing. Biomass smoke exposure COPD affects primarily women and is related with insults to the airways occurred during early life. Although constituents of biomass smoke and tobacco smoke are similar, the physiopathological changes they induce differ depending not only on the chemical composition (related with the type of fuel used) but also on the particle size and the inhalation pattern. Evidence has shown that biomass smoke exposure affects the airway, predominantly the small airways causing anthracofibrosis and peribronchiolar fibrosis changes that will clinically translate into chronic bronchitis symptoms, with a high impact on the quality of life. In this review, we focus especially on the main epidemiological and clinical differences between COPD secondary to biomass exposure and COPD caused by tobacco exposure.


REFERENCES

  1. Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122.

  2. Han MK, Agustí A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes. Am J Respir Crit Care Med. 2010; 182:598-604.

  3. Celli BR, Agustí A. COPD: time to improve its taxonomy? ERJ Open Res. 2018;4:00132-2017.

  4. Agustí A, Celli B. Natural history of COPD: gaps and opportunities. ERJ Open Res. 2017;3:00117-2017.

  5. Agustí A, Sobradillo P, Celli B. Addressing the complexity of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183:1129-37.

  6. Pérez-Padilla R, Ramírez-Venegas A, Sansores-Martínez R. Clinical characteristics of patients with biomass smoke-associated COPD and chronic bronchitis, 2004-2014. Chronic Obstr Pulm Dis. 2014;1:23-32.

  7. Assad N, Balmes J, Mehta S, Cheema U, Sood A. Chronic obstructive pulmonary disease secondary to household air pollution. Semin Respir Crit Care Med. 2015;36:408-21.

  8. Zhao D, Zhou Y, Jiang C, et al. Small airway disease: a different phenotype of early stage COPD associated with biomass smoke exposure. Respirology. 2018;23:198-05.

  9. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374:733-43.

  10. Slade J. The tobacco epidemic: lessons from history. J Psychoactive Drugs. 1989;21:281-91.

  11. Kodgule R, Salvi S. Exposure to biomass smoke as a cause for airway disease in women and children. Curr Opin Allergy Clin Immunol. 2012;12:82-90.

  12. Biomass.net. Following the Energy Trail With Biomass History. Available from: http://www.biomass.net/Biomass-History.html. [Last accessed on 2018 Apr 10th].

  13. Hurt RD, Murphy JG, Dunn WF. Did we finally slay the evil dragon of cigarette smoking in the late 20th century? Unfortunately, the answer is no-the dragon is still alive and well in the 21st century and living in the third world. Shame on us! Chest. 2014; 146:1438-43.

  14. Gordon SB, Bruce NG, Grigg J, et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med. 2014;2:823-60.

  15. Global Health Observatory. World Health Organization. Available from: http://www.who.int/gho/phe/en/. [Last accessed on 2018 Apr 10th].

  16. Eisner MD, Anthonisen N, Coultas D, et al. An official American thoracic society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182:693-18.

  17. Ramírez-Venegas A, Sansores RH, Velázquez-Uncal M, Pérez- Bautista O. Nonsmokers and biomass exposure. ERS Monogr. 2015;69:35-46.

  18. Caballero A, Torres-Duque CA, Jaramillo C, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008;133:343-9.

  19. Balakrishnan K, Sambandam S, Ramaswamy P, Mehta S, Smith KR. Exposure assessment for respirable particulates associated with household fuel use in rural districts of Andhra Pradesh, India. J Expo Sci Environ Epidemiol. 2004; 14:S14-25.

  20. Balakrishnan K, Sankar S, Parikh J, et al. Daily average exposures to respirable particulate matter from combustion of biomass fuels in rural households of southern India. Environ Health Perspect. 2002;110:1069-75.

  21. Naeher LP, Brauer M, Lipsett M, et al. Woodsmoke health effects: a review. Inhal Toxicol. 2007;19:67-6.

  22. Brauer M, Hirtle RD, Hall AC, Yip TR. Monitoring personal fine particle exposure with a particle counter. J Expo Anal Environ Epidemiol. 1999;9:228-36.

  23. Salvi S, Barnes PJ. Is exposure to biomass smoke the biggest risk factor for COPD globally? Chest. 2010;138:3-6.

  24. Postma DS, Bush A, van den Berge M. Risk factors and early origins of chronic obstructive pulmonary disease. Lancet. 2015; 385:899-909.

  25. Heinzerling AP, Guarnieri MJ, Mann JK, et al. Lung function in woodsmoke-exposed Guatemalan children following a chimney stove intervention. Thorax. 2016;71:421-8.

  26. Hayatbakhsh MR, Sadasivam S, Mamun AA, et al. Maternal smoking during and after pregnancy and lung function in early adulthood: a prospective study. Thorax. 2009;64:810-4.

  27. Kulkarni N, Pierse N, Rushton L, Grigg J. Carbon in airway macrophages and lung function in children. N Engl J Med. 2006; 355:21-30.

  28. Mishra V, Retherford RD. Cooking smoke increases the risk of acute respiratory infection in children. Natl Fam Health Surv Bull. 1997;8:1-4.

  29. Po JYT, FitzGerald JM, Carlsten C. Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis. Thorax. 2011;66:232-9.

  30. Martinez FD. Early-life origins of chronic obstructive pulmonary disease. N Engl J Med. 2016;375:871-8.

  31. Stocks J, Hislop A, Sonnappa S. Early lung development: lifelong effect on respiratory health and disease. Lancet Respir Med. 2013;1:728-42.

  32. Bernstein DM. A review of the influence of particle size, puff volume, and inhalation pattern on the deposition of cigarette smoke particles in the respiratory tract. Inhal Toxico. 2004; 16:675-89.

  33. Rivera RM, Cosío MG, Ghezzo H, Salazar M, Pérez-Padilla R. Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis. 2008;12:972-7.

  34. Torres-Duque CA, García-Rodriguez MC, González-García M. Is chronic obstructive pulmonary disease caused by wood smoke a different phenotype or a different entity? Arch Bronconeumol. 2016;52:425-31.

  35. Perret JL, Abramson MJ. Biomass smoke COPD: a phenotype or a different disease? Respirology. 2018;23:124-5.

  36. Camp PG, Ramírez-Venegas A, Sansores RH, et al. COPD phenotypes in biomass smoke-versus tobacco smoke-exposed Mexican women. Eur Respir J. 2014;43:725-34.

  37. González-García M, Maldonado Gómez D, Torres-Duque CA, et al. Tomographic and functional findings in severe COPD: comparison between the wood smoke-related and smoking-related disease. J Bras Pneumol. 2013;39:147-54.

  38. Fernandes L, Gulati N, Fernandes Y, et al. Small airway imaging phenotypes in biomass- and tobacco smoke-exposed patients with COPD. ERJ Open Res 2017; 3: 00124-2016.

  39. Kim YJ, Jung CY, Shin HW, Lee BK. Biomass smoke induced bronchial anthracofibrosis: presenting features and clinical course. Respir Med. 2009;103:757-65.

  40. Gupta A, Shah A. Bronchial anthracofibrosis: an emerging pulmonary disease due to biomass fuel exposure. Int J Tuberc Lung Dis. 2011;15:602-12.

  41. Kim H, Cha SI, Shin KM, et al. Clinical relevance of bronchial anthracofibrosis in patients with chronic obstructive pulmonary disease exacerbation. Tuberc Respir Dis. 2014;77:124-31.

  42. Morán-Mendoza O, Pérez-Padilla JR, Salazar-Flores M, Vázquez- Alfaro F. Wood smoke-associated lung disease: a clinical, functional, radiological and pathological description. Int J Tuberc Lung Dis. 2008;12:1092-8.

  43. Palacios DM, Méndez O. NeumopatÍa por humo de leña. Un estudio en autopsias. Biomédica. 1998;18:153.

  44. Restrepo J, Reyes P, De Ochoa P, Patiño E. Neumoconiosis por inhalación del humo de leña. Acta Med Colomb. 1983;8:191-4.

  45. González M, Páez S, Jaramillo C, Barrero M, Maldonado D. Enfermedad pulmonar obstructiva crónica (EPOC) por humo de leña en mujeres: comparación con la EPOC por tabaquismo. Acta Med Colomb. 2004;29:17-25.

  46. Moreira MA, Barbosa MA, Queiroz MC, et al. Pulmonary changes on HRCT scans in nonsmoking females with COPD due to wood smoke exposure. J Bras Pneumol. 2013;39:155-63.

  47. Sana A, Somda SM, Meda N, Bouland C. Chronic obstructive pulmonary disease associated with biomass fuel use in women: a systematic review and meta-analysis. BMJ Open Respir Res. 2018;5:e000246.

  48. Golpe R, Sanjuán López P, Cano Jiménez E, Castro Añón O, Pérez de Llano LA. Distribución de fenotipos clínicos en pacientes con enfermedad pulmonar obstructiva crónica por humo de biomasa y por tabaco. Arch Bronconeumol. 2014;50:318-24.

  49. González-Garcia M, Caballero A, Jaramillo C, Torres-Duque CA. Chronic bronchitis: high prevalence in never smokers and underdiagnosis- a population-based study in Colombia. Chron Respir Dis. 2018,1:1-8.

  50. Kurmi OP, Semple S, Simkhada P, Smith WC, Ayres JG. COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. Thorax. 2010;65:221-8.

  51. Moreira MA, Moraes MR, Silva DG, et al. Comparative study of respiratory symptoms and lung function alterations in patients with chronic obstructive pulmonary disease related to the exposure to wood and tobacco smoke. J Bras Pneumol. 2008; 34:667-74.

  52. González-García M, Gómez V, Perlaza I, Casas A. Diferencias en el impacto sobre el estado de salud entre la EPOC por cigarrillo y por humo de leña. Arch Bronconeumol. 2014;50:59.

  53. Ramírez-Venegas A, Velázquez-Uncal M, Pérez-Hernández R, et al. Prevalence of COPD and respiratory symptoms associated with biomass smoke exposure in a suburban area. Int J Chron Obs Pulmon Dis. 2018;13:1727-34.

  54. Ramírez-Venegas A, Sansores RH, Pérez-Padilla R, et al. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med. 2006;173:393-7.

  55. Olloquequi J, Jaime S, Parra V, et al. Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both. Respir Res. 2018;19:1-8.

  56. Torres-Duque CA, Caballero A, González-García M, Jaramillo C. Chronic obstructive pulmonary disease in people exposed to wood smoke. PREPOCOL: a population based study. Am J Respir Crit Care Med. 2013;187:A3644.

  57. Ramírez-Venegas A, Sansores RH, Quintana-Carrillo RH, et al. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure. Am J Respir Crit Care Med. 2014;190:996-2.

  58. Golpe R, Mengual-Macenlle N, Sanjuan-López P, et al. Prognostic indices and mortality prediction in COPD caused by biomass smoke exposure. Lung. 2015;193:497-3.

  59. Gelb AF, Zamel N, Hogg JC, Müller NL, Schein MJ. Pseudophysiologic emphysema resulting from severe small-airways disease. Am J Respir Crit Care Med. 1998;158:815-9.

  60. González-García M, Torres C, Jaramillo C, Maldonado D, Bustos D. Bronchial hyperresponsiveness in women with chronic obstructive pulmonary disease related to wood smoke. Int J Chron Obstruct Pulmon Dis. 2012;7:367-73.

  61. Guzmán-Bouilloud NE, Velázquez-Uncal M, Aranda-Chávez A, et al. Roll of small airways in patients with chronic obstructive pulmonary disease associated to biomass smoke. Am J Respir Crit Care Med. 2017;195:A5009.

  62. Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Guía española de la EPOC (GesEPOC). Actualización 2014. Arch Bronconeumol. 2014;50:1-16.

  63. Sertogullarindan B, Gumrukcuoglu HA, Sezgi C, Akil MA. Frequency of pulmonary hypertension in patients with COPD due to biomass smoke and tobacco smoke. Int J Med Sci. 2012; 9:406-12.

  64. Sandoval J, Salas J, Martínez-Guerra ML, et al. Pulmonary arterial hypertension and cor pulmonale associated with chronic domestic woodsmoke inhalation. Chest. 1993;103:12-20.

  65. Mehra D, Geraghty PM, Hardigan AA, Foronjy R. A Comparison of the inflammatory and proteolytic effects of dung biomass and cigarette smoke exposure in the lung. PLoS One. 2012; 7:e52889.




2020     |     www.medigraphic.com